Akt determines replicative senescence and oxidative or oncogenic premature senescence and sensitizes cells to oxidative apoptosis
By V. Nogueira, Youngkyu Park, Chia-Chen Chen, Pei-Zhang Xu, Mei-Ling Chen, Ivana Tonic, T. Unterman, N. Hay. Cancer Cell, 2008
771 citations recorded by the source corpus.
Summary Akt-deficiency causes resistance to replicative senescence, oxidative stress- or oncogenic Ras-induced premature senescence, and to reactive oxygen species (ROS)-mediated apoptosis. Akt activation induces premature senescence and sensitizes cells to ROS-mediated apoptosis by increasing intracellular ROS through increased oxygen consumption and by inhibiting the expression of ROS-scavengers downstream of FoxO, particularly sestrin3 expression. This uncovers an Achilles’ heel of Akt, since in contrast to its ability to inhibit apoptosis induced by multiple apoptotic stimuli; Akt could not inhibit ROS-mediated apoptosis. Furthermore, treatment with rapamycin that led to further Akt activation and resistance to etoposide, hypersensitized cancer cells to ROS-mediated apoptosis. Given that rapamycin alone is mainly cytostatic, this constitutes a strategy for cancer therapy that selectively eradicates cancer cells via Akt activation.
Subfields: Molecular Biology
View Paper: https://www.semanticscholar.org/paper/47ae93b1c962b3a2ea9f0dfe1857353c66cb6a7e
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Molecular Biology
- Navdeep S. Chandel
- Michael Schieber
- G. Poulogiannis
- Jie Zheng
- J. Asara
- Lewis C. Cantley
- I. Harris
- R. Cairns
Citations in the corpus
- Energy metabolism of cancer: Glycolysis versus oxidative phosphorylation (Review). (2012, background): “In addition, lactic acidosis inhibits glycolysis and favors aerobic respiration as a means of energy generation (14). ⅳ) Due to the decrease of mitochondrial OXPHOS, less reactive oxygen species (ROS) are generated, which are cytotoxic to cancer cells (34,35).”
- Redox regulation of FoxO transcription factors (2015, background): “In human fibroblasts, E2F-1 enhances cellular senescence, whereas FoxOs antagonize senescence by upregulating the formation of ROS scavenging proteins [154,155].”
- The Role of Sirtuins in Antioxidant and Redox Signaling (2017, background): “This raises metabolic activity in the mitochondria and inhibits FOXO transcriptional activity, resulting in greatly increased ROS levels, which sensitizes cancer cells to apoptosis induced by oxidative stimuli (35, 115).”
- Regulation of cancer cell metabolism (2011, result): “Similar results have been seen with loss of PTEN, and hyperactivation of AKT1 leads to FOXO inactivation and increased oxidative stres”
- Senescence and apoptosis: dueling or complementary cell fates? (2014, neutral): “Conversely, AKT deficiency confers resistance to replicative- and Ras-induced senescence and promotes apoptosis under conditions of oxidative stress [77].”
- ROS Function in Redox Signaling and Oxidative Stress (2014, background): “If cancer cells do not control their ROS levels then they are susceptible to oxidative-stress-induced cell death [46,47].”
- Depletion of a Putatively Druggable Class of Phosphatidylinositol Kinases Inhibits Growth of p53-Null Tumors (2013, background): “Hyperactivation of the PI3K/AKT pathway due to loss of PTEN (and INPP4B) has previously been shown to induce senescence (Chen et al., 2005; Gewinner et al., 2009; Nogueira et al., 2008), raising the possibility that activation of AKT in response to PI5P4Ka/b knockdown is responsible for the senescen”
- Fasting Cycles Retard Growth of Tumors and Sensitize a Range of Cancer Cell Types to Chemotherapy (2012, background): “In both yeast and higher eukaryotes, the activation of Akt and TOR-S6K pathways promotes oxidative stress and sensitizes cells to oxidative damage, in part by in activating stress resistance transcription factors (26, 27).”